| |
| |
|
| Insider
Information: |
Bird Jeffrey W |
| Relationship: |
Director, 10% Owner |
| City: |
Palo Alto |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
9 |
|
| Direct
Shares |
8,735,679 |
|
|
Indirect Shares
|
2,993,315 |
|
|
| Direct
Value |
$160,554,946 |
|
|
|
Indirect Value
|
$15,922,819 |
|
|
| Total
Shares |
11,728,994 |
|
|
| Total
Value |
$176,477,765 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
0
|
|
Stock
price went up :
|
2
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
2.0
|
0.0
|
| Percentage
Gain/Loss : |
 498.3%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Mattersight Corporation |
MATR |
10% Owner |
2003-09-26 |
0 |
2017-06-01 |
1,128,034 |
Premium* |
|
|
Corcept Therapeutics Inc |
CORT |
Director, 10% Owner |
2012-03-29 |
5,316,967 |
2011-10-21 |
229,567 |
Premium* |
|
|
Dextera Surgical Inc |
DXTR |
Director, 10% Owner |
2013-03-20 |
3,412,793 |
2013-03-20 |
170,977 |
Premium* |
|
|
Molecular Templates, Inc. |
MTEM |
Director |
2017-06-01 |
919 |
2017-06-01 |
377,782 |
Premium* |
|
|
Quinstreet, Inc |
QNST |
10% Owner |
|
0 |
2010-02-10 |
1,114 |
Premium* |
|
|
Horizon Pharma, Inc. |
HZNP |
Director |
2013-12-13 |
5,000 |
2013-12-13 |
178,406 |
Premium* |
|
|
Portola Pharmaceuticals Inc |
PTLA |
Director |
2020-07-02 |
0 |
2020-07-02 |
0 |
Premium* |
|
|
Yext Inc |
YEXT |
10% Owner |
|
0 |
2017-12-01 |
724,841 |
Premium* |
|
|
Venus Concept Inc |
VERO |
Director, 10% Owner |
2017-10-16 |
0 |
2017-10-16 |
182,594 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
143 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 5 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CORT |
Corcept Therapeutics Inc |
officerTitle |
– – • |
2005-12-08 |
4 |
D |
$0.00 |
$0 |
I/I |
(5,539) |
2,210,649 |
|
- |
|
| CORT |
Corcept Therapeutics Inc |
10% Owner |
– – • |
2007-09-21 |
4 |
D |
$0.00 |
$0 |
I/I |
(468,492) |
3,075,113 |
0 |
- |
|
| MATR |
Mattersight Corporation |
10% Owner |
– – • |
2008-03-07 |
4 |
D |
$0.00 |
$0 |
I/I |
(82,799) |
673,068 |
0 |
- |
|
| MTEM |
Molecular Templates, Inc. |
Director |
– • • |
2011-12-09 |
4 |
D |
$0.00 |
$0 |
D/D |
(386,307) |
3,983,645 |
0 |
- |
|
| MATR |
Mattersight Corporation |
10% Owner |
– – • |
2011-12-22 |
4 |
D |
$0.00 |
$0 |
I/I |
(92,368) |
1,859 |
0 |
- |
|
| MATR |
Mattersight Corporation |
10% Owner |
• • • |
2012-01-01 |
5 |
D |
$0.00 |
$0 |
I/I |
(0) |
92,368 |
0 |
- |
|
| MATR |
Mattersight Corporation |
10% Owner |
• • • |
2012-01-02 |
5 |
D |
$0.00 |
$0 |
I/I |
(0) |
92,368 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Director |
• • – |
2012-07-25 |
4 |
D |
$0.00 |
$0 |
I/I |
(59,622) |
1,550,358 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Director |
• • – |
2013-01-01 |
5 |
D |
$0.00 |
$0 |
I/I |
(0) |
7,000 |
0 |
- |
|
| MATR |
Mattersight Corporation |
10% Owner |
• • • |
2013-01-01 |
5 |
D |
$0.00 |
$0 |
I/I |
(0) |
92,368 |
0 |
- |
|
| MATR |
Mattersight Corporation |
10% Owner |
• • • |
2014-01-01 |
5 |
D |
$0.00 |
$0 |
I/I |
(0) |
92,368 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Director |
• • – |
2015-01-01 |
5/A |
D |
$0.00 |
$0 |
I/I |
(0) |
36,602 |
0 |
- |
|
| MATR |
Mattersight Corporation |
10% Owner |
• • • |
2015-11-19 |
4 |
D |
$0.00 |
$0 |
I/I |
(319,847) |
1,124,042 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Director |
• • – |
2015-12-04 |
4 |
D |
$0.00 |
$0 |
I/I |
(144,333) |
958,491 |
0 |
- |
|
| MTEM |
Molecular Templates, Inc. |
Director |
• • – |
2016-03-01 |
4 |
D |
$0.00 |
$0 |
I/I |
(617,132) |
4,098,266 |
0 |
- |
|
| MTEM |
Molecular Templates, Inc. |
Director |
• • – |
2017-05-31 |
4 |
D |
$0.00 |
$0 |
I/I |
(630,770) |
3,467,496 |
0 |
- |
|
| MATR |
Mattersight Corporation |
10% Owner |
• • • |
2017-05-31 |
4 |
D |
$0.00 |
$0 |
I/I |
(271,391) |
852,651 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Director |
• • – |
2017-05-31 |
4 |
D |
$0.00 |
$0 |
I/I |
(147,523) |
810,968 |
0 |
- |
|
| YEXT |
Yext Inc |
10% Owner |
• • • |
2017-12-01 |
4 |
D |
$0.00 |
$0 |
I/I |
(8,614,633) |
0 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Director |
• • – |
2019-09-03 |
4 |
D |
$0.00 |
$0 |
I/I |
(921,610) |
0 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Director |
• • – |
2020-07-02 |
4 |
D |
$18.00 |
$368,550 |
D/D |
(20,475) |
0 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Director |
• • – |
2020-07-02 |
4 |
D |
$18.00 |
$9,251,604 |
I/I |
(513,978) |
0 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Director |
• • – |
2016-01-01 |
5 |
GD |
$0.00 |
$0 |
I/I |
0 |
36,602 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Director |
• • – |
2016-10-01 |
5 |
GD |
$0.00 |
$0 |
I/I |
0 |
36,602 |
0 |
- |
|
| MATR |
Mattersight Corporation |
10% Owner |
– – • |
2003-07-01 |
3/A |
IO |
$0.00 |
$0 |
I/I |
0 |
399,767 |
|
- |
|
143 Records found
|
|
Page 5 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
